Top analyst drops jaw-dropping price target on Eli Lilly stock
Bernstein just threw fresh fuel on Eli Lilly's (LLY) never-ending rally, as the firm lifted its price target on the stock to $1,300 from $1,100. For
(TheStreet, 2025-11-25T17:33:00Z)